{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:17:37Z","timestamp":1791505057983,"version":"4.3.4"},"reference-count":87,"publisher":"Tech Science Press","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Cytokine Netw"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1684\/ecn.2019.0433","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T17:52:21Z","timestamp":1697824341000},"page":"74-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Zika virus in the eye of the cytokine storm"],"prefix":"10.32604","volume":"30","author":[{"given":"Christopher","family":"Maucourant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Andrade Nonato","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assia","family":"Samri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda Rios","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Yssel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Vieillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"key":"433_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","volume":"46","author":"GW Dick","year":"1952","unstructured":"Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Tropl Med Hyg 1952; 46: 509\u201320.","journal-title":"Trans R Soc Tropl Med Hyg"},{"key":"433_CR2","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","volume":"360","author":"MR Duffy","year":"2009","unstructured":"Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap island, federated states of Micronesia. N Engl J Med 2009; 360: 2536\u201343.","journal-title":"N Engl J Med"},{"key":"433_CR3","first-page":"el72","volume":"18","author":"D Musso","year":"2018","unstructured":"Musso D, Bossin H, Mallet HP, et al. Zika virus in French Polynesia 2013-14: anatomy of a completed outbreak. Lancet Infect Dis 2018; 18: el72\u201382.","journal-title":"Lancet Infect Dis"},{"key":"433_CR4","doi-asserted-by":"publisher","first-page":"E4334","DOI":"10.1073\/pnas.1620161114","volume":"114","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Sun K, Chinazzi M, et al. Spread of Zika virus in the Americas. Proc Natl Acad Sci USA 2017; 114: E4334\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"433_CR5","volume-title":"WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations.","author":"WHO.","year":"2016","unstructured":"WHO. WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations. 2016. http:\/\/www.who.int\/mediacentre\/news\/statements\/2016\/lst-emergency-committee-zika\/en\/ (accessed March 16, 2016)."},{"key":"433_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","volume":"71","author":"EA Gould","year":"2008","unstructured":"Gould EA, Solomon T. Pathogenic flaviviruses. Lancet 2008; 71: 500\u20139.","journal-title":"Lancet"},{"key":"433_CR7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barr. Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016; 387: 1531\u20139.","journal-title":"Lancet"},{"key":"433_CR8","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMc1602964","volume":"374","author":"G Carteaux","year":"2016","unstructured":"Carteaux G, Maquart M, Bedet A, et al. Zika virus associated with meningoencephalitis. N Engl J Med 2016; 374: 1595\u20136.","journal-title":"N Engl J Med"},{"key":"433_CR9","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0140-6736(16)00644-9","volume":"387","author":"S Mecharles","year":"2016","unstructured":"Mecharles S, Herrmann C, Poullain P, et al. Acute myelitis due to Zika virus infection. Lancet 2016; 387: 1481.","journal-title":"Lancet"},{"key":"433_CR10","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3201\/eid2110.150847","volume":"21","author":"GS Campos","year":"2015","unstructured":"Campos GS, Bandeira AC, Sardi SI. Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis 2015; 21: 1885\u20136.","journal-title":"Emerg Infect Dis"},{"key":"433_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0140-6736(16)00006-4","volume":"387","author":"CV Ventura","year":"2016","unstructured":"Ventura CV, Maia M, Bravo-Filho V, G\u00f3is AL, Beifort Jr R. Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet 2016; 387: 228.","journal-title":"Lancet"},{"key":"433_CR12","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJMoa1600651","volume":"374","author":"J Mlakar","year":"2016","unstructured":"Mlakar J, Korva M, Tul N, et al. Zika virus associated with microcephaly. N Engl J Med 2016; 374: 951\u20138.","journal-title":"N Engl J Med"},{"key":"433_CR13","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMc1604449","volume":"374","author":"E D\u2019Ortenzio","year":"2016","unstructured":"D\u2019Ortenzio E, Matheron S, Yazdanpanah Y, et al. Evidence of sexual transmission of Zika virus. N Engl J Med 2016; 374: 2195\u20138.","journal-title":"N Engl J Med"},{"key":"433_CR14","doi-asserted-by":"publisher","first-page":"30316","DOI":"10.2807\/1560-7917.ES.2016.21.32.30316","volume":"21","author":"L Barzon","year":"2016","unstructured":"Barzon L, Pacenti M, Franchin E, et al. Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016. Eurosurveillance 2016; 21: 30316.","journal-title":"Eurosurveillance"},{"key":"433_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3201\/eid2301.161394","volume":"23","author":"KO Murray","year":"2017","unstructured":"Murray KO, Gorchakov R, Carlson AR, et al. Prolonged detection of Zika virus in vaginal secretions and whole blood. Emerg Infect Dis 2017; 23: 99\u2013101.","journal-title":"Emerg Infect Dis"},{"key":"433_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41579-018-0134-9","volume":"17","author":"ZY Liu","year":"2019","unstructured":"Liu ZY, Shi WF, Qin CF. The evolution of Zika virus from Asia to the Americas. Nat Rev Microbiol 2019; 17: 131\u20139.","journal-title":"Nat Rev Microbiol"},{"key":"433_CR17","doi-asserted-by":"publisher","first-page":"e646","DOI":"10.1371\/journal.pntd.0000646","volume":"4","author":"L Lambrechts","year":"2010","unstructured":"Lambrechts L, Scott TW, Gubler DJ. Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Negl Trop Dis 2010; 4: e646.","journal-title":"PLoS Negl Trop Dis"},{"key":"433_CR18","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jaci.2015.01.039","volume":"135","author":"C Petitdemange","year":"2015","unstructured":"Petitdemange C, Wauquier N, Vieillard V. Control of immunopathology during Chikungunya virus infection. J Allergy Clin Immunol 2015; 135: 846\u201355.","journal-title":"J Allergy Clin Immunol"},{"key":"433_CR19","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.1128\/JVI.00354-15","volume":"89","author":"R Hamel","year":"2015","unstructured":"Hamel R, Dejarnac O, Wichit S, et al. Biology of Zika virus infection in human skin cells. J Virol 2015; 89: 8880\u201396.","journal-title":"J Virol"},{"key":"433_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2016.03.012","volume":"18","author":"TJ Nowakowski","year":"2016","unstructured":"Nowakowski TJ, Pollen AA, Di Lullo E, Sandoval-Espinosa C, Bershteyn M, Kriegstein AR. Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells. Cell Stem Cell 2016; 18: 591\u20136.","journal-title":"Cell Stem Cell"},{"key":"433_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","volume":"36","author":"AE Ngono","year":"2018","unstructured":"Ngono AE, Shresta S. Immune response to Dengue and Zika. Annu Rev Immunol 2018; 36: 279\u2013308.","journal-title":"Annu Rev Immunol"},{"key":"433_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nature04946","volume":"442","author":"E Meylan","year":"2006","unstructured":"Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006; 442: 39\u201344.","journal-title":"Nature"},{"key":"433_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri2314","volume":"8","author":"AJ Sadler","year":"2008","unstructured":"Sadler AJ, Williams BRG. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008; 8: 559\u201368.","journal-title":"Nat Rev Immunol"},{"key":"433_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nri1900","volume":"6","author":"K Honda","year":"2006","unstructured":"Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006; 6: 644\u201358.","journal-title":"Nat Rev Immunol"},{"key":"433_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","volume":"1","author":"J Schoggins","year":"2011","unstructured":"Schoggins J, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 2011; 1: 519\u201325.","journal-title":"Curr Opin Virol"},{"key":"433_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.mib.2010.05.009","volume":"13","author":"GA Versteeg","year":"2010","unstructured":"Versteeg GA, Garcia-Sastre A. Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 2010; 13: 508\u201316.","journal-title":"Curr Opin Microbiol"},{"key":"433_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.chom.2015.06.007","volume":"18","author":"KJ Lubick","year":"2015","unstructured":"Lubick KJ, Robertson SJ, McNally KL, et al. Flavivirus antagonism of type I interferon signaling reveals prolidase as a regulator of IFNAR1 surface expression. Cell Host Microbe 2015; 18: 61\u201374.","journal-title":"Cell Host Microbe"},{"key":"433_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.chom.2014.07.015","volume":"16","author":"M Laurent-Rolle","year":"2014","unstructured":"Laurent-Rolle M, Morrison J, Rajsbaum R, et al. The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. Cell Host Microbe 2014; 16: 314\u201327.","journal-title":"Cell Host Microbe"},{"key":"433_CR29","doi-asserted-by":"publisher","first-page":"el003265","DOI":"10.1371\/journal.ppat.1003265","volume":"9","author":"J Morrison","year":"2013","unstructured":"Morrison J, Laurent-Rolle M, Maestre AM, et al. Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog 2013; 9: el003265.","journal-title":"PLoS Pathog"},{"key":"433_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.chom.2016.05.009","volume":"19","author":"A Grant","year":"2016","unstructured":"Grant A, Ponia SS, Tripathi S, et al. Zika virus targets human STAT2 to inhibit type I interferon signaling. Cell Host Microbe 2016; 19: 882\u201390.","journal-title":"Cell Host Microbe"},{"key":"433_CR31","doi-asserted-by":"publisher","first-page":"E1587","DOI":"10.1073\/pnas.1616097114","volume":"114","author":"MA Sheridan","year":"2017","unstructured":"Sheridan MA, Yunusov D, Balaraman V, Alexenko AP, Yabe S, Verjovski-Almeida S. Vulnerability of primitive human placental trophoblast to Zika virus. Proc Natl Acad Sci USA 2017; 114: E1587\u201396.","journal-title":"Proc Natl Acad Sci USA"},{"key":"433_CR32","doi-asserted-by":"publisher","first-page":"11515","DOI":"10.1128\/JVI.01703-09","volume":"84","author":"NA Jewell","year":"2010","unstructured":"Jewell NA, Cline T, Mertz SE, et al. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 2010; 84: 11515\u201322.","journal-title":"J Virol"},{"key":"433_CR33","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1093\/humrep\/17.9.2243","volume":"17","author":"JJ Tar\u00edn","year":"2002","unstructured":"Tar\u00edn JJ, G\u00f3mez-Piquer V. Do women have a hidden heat period? Hum Reprod 2002; 17: 2243\u20138.","journal-title":"Hum Reprod"},{"key":"433_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2016.03.008","volume":"19","author":"A Bayer","year":"2016","unstructured":"Bayer A, Lennemann NJ, Ouyang Y, et al. Type III interferons produced by human placental trophoblasts confer protection against Zika virus infection. Cell Host Microbe 2016; 19: 705\u201312.","journal-title":"Cell Host Microbe"},{"key":"433_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41467-018-07993-2","volume":"10","author":"EA Caine","year":"2019","unstructured":"Caine EA, Scheaffer SM, Arora N, et al. Interferon lambda protects the female reproductive tract against Zika virus infection. Nat Commun 2019; 10: 280.","journal-title":"Nat Commun"},{"key":"433_CR36","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/infdis\/jiy225","volume":"218","author":"FM Lum","year":"2018","unstructured":"Lum FM, Lye DCB, Tan JJL, et al. Longitudinal study of cellular and systemic cytokine signatures to define the dynamics of a balanced immune environment during disease manifestation in Zika virus-infected patients. J Infect Dis 2018; 218: 814\u201324.","journal-title":"J Infect Dis"},{"key":"433_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00430-015-0445-7","volume":"205","author":"D Tappe","year":"2016","unstructured":"Tappe D, P\u00e9rez-Gir\u00f3n JV, Zammarchi L, et al. Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase. Med Microbiol Immunol 2016; 205: 269\u201373.","journal-title":"Med Microbiol Immunol"},{"key":"433_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3389\/fimmu.2018.00821","volume":"9","author":"JBS Barros","year":"2018","unstructured":"Barros JBS, da Silva PAN, Koga RCR, et al. Acute Zika virus infection in an endemic area shows modest proinflammatory systemic immunoactivation and cytokine-symptom associations. Front Immunol 2018; 9: 821.","journal-title":"Front Immunol"},{"key":"433_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","volume":"32","author":"WM Schneider","year":"2014","unstructured":"Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 2014; 32: 513\u201345.","journal-title":"Annu Rev Immunol"},{"key":"433_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1600-065X.2006.00460.x","volume":"214","author":"S Gasser","year":"2006","unstructured":"Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells. Immunol Rev 2006; 214: 130\u201342.","journal-title":"Immunol Rev"},{"key":"433_CR41","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nri3044","volume":"11","author":"JC Sun","year":"2011","unstructured":"Sun JC, Lanier LL. NK cell development, homeostasis and function: parallels with CD8+ Tcells. Nat Rev Immunol 2011; 11: 645\u201357.","journal-title":"Nat Rev Immunol"},{"key":"433_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","volume":"331","author":"E Vivier","year":"2011","unstructured":"Vivier E, Raulet DH, Moretta A, et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331: 44\u20139.","journal-title":"Science"},{"key":"433_CR43","doi-asserted-by":"publisher","first-page":"e00785","DOI":"10.1128\/JVI.00785-17","volume":"91","author":"A Glasner","year":"2017","unstructured":"Glasner A, Oiknine-Djian E, Weisblum Y, et al. Zika virus escapes NK cell detection by upregulating major histocompatibility complex class I molecules. J Virol 2017; 91: e00785\u2013817.","journal-title":"J Virol"},{"key":"433_CR44","doi-asserted-by":"publisher","first-page":"e00120","DOI":"10.1128\/mSphereDirect.00120-18","volume":"3","author":"FM Lum","year":"2018","unstructured":"Lum FM, Lee D, Chua TK, et al. Zika virus infection preferentially counterbalances human peripheral monocyte and\/or NK cell activity. mSphere 2018; 3: e00120\u2013218.","journal-title":"mSphere"},{"key":"433_CR45","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.3390\/v11020131","volume":"11","author":"C Maucourant","year":"2019","unstructured":"Maucourant C, Petitdemange C, Yssel H, Vieillard V. Control of acute arboviral infection by natural killer cells. Viruses 2019; 11: E131.","journal-title":"Viruses"},{"key":"433_CR46","doi-asserted-by":"publisher","first-page":"e0004499","DOI":"10.1371\/journal.pntd.0004499","volume":"10","author":"C Petitdemange","year":"2016","unstructured":"Petitdemange C, Wauquier N, Devilliers H, et al. Longitudinal analysis of natural killer cells in Dengue virus-infected patients in comparison to Chikungunya and Chikungunya\/Dengue virus-infected patients. PLoS Negl Trop Dis 2016; 10: e0004499.","journal-title":"PLoS Negl Trop Dis"},{"key":"433_CR47","doi-asserted-by":"publisher","first-page":"el002268","DOI":"10.1371\/journal.ppat.1002268","volume":"7","author":"C Petitdemange","year":"2011","unstructured":"Petitdemange C, Becquart P, Wauquier N, et al. Unconventional repertoire profile is imprinted during acute Chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog 2011; 7: el002268.","journal-title":"PLoS Pathog"},{"key":"433_CR48","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1002\/eji.201243050","volume":"42","author":"KJ Malmberg","year":"2012","unstructured":"Malmberg KJ, Beziat V, Ljunggren HG. Spotlight on NKG2C and the human NK-cell response to CMV infection. Eur J Immunol 2012; 42: 3141\u20135.","journal-title":"Eur J Immunol"},{"key":"433_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2172-11-3","volume":"11","author":"M Zhang","year":"2010","unstructured":"Zhang M, Daniel S, Huang Y, et al. Anti-West Nile virus activity of in vitro expanded human primary natural killer cells. BMC Immunol 2010; 11: 3.","journal-title":"BMC Immunol"},{"key":"433_CR50","doi-asserted-by":"publisher","first-page":"e00163","DOI":"10.1128\/JVI.00163-17","volume":"91","author":"V Chaudhary","year":"2017","unstructured":"Chaudhary V, Yuen KS, Chan JF, et al. Selective activation of type ii interferon signaling by Zika virus NS5 protein. J Virol 2017; 91: e00163\u2013217.","journal-title":"J Virol"},{"key":"433_CR51","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00705-015-2410-6","volume":"160","author":"N Pandey","year":"2015","unstructured":"Pandey N, Jain A, Garg RK, et al. Serum levels of IL-8, IFN\u03b3, IL-10 and TGF \u00df and their gene expression levels in severe and non-severe cases of dengue virus infection. Arch Virol 2015; 160: 1463\u201375.","journal-title":"Arch Virol"},{"key":"433_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/infdis\/jiw494","volume":"215","author":"Z Her","year":"2017","unstructured":"Her Z, Kam YW, Gan VC, et al. Severity of plasma leakage is associated with high levels of interferon \u03b3-inducible protein 10, hepatocyte growth factor, matrix metalloproteinase 2 (MMP-2) and MMP-9 during Dengue virus infection. J Infect Dis 2017; 215: 42\u201351.","journal-title":"J Infect Dis"},{"key":"433_CR53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12879-016-1596-x","volume":"16","author":"L Zhao","year":"2016","unstructured":"Zhao L, Huang X, Hong W, et al. Slow resolution of inflammation in severe adult dengue patients. BMC Infect Dis 2016; 16: 291.","journal-title":"BMC Infect Dis"},{"key":"433_CR54","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","volume":"17","author":"W Dejnirattisai","year":"2016","unstructured":"Dejnirattisai W, Supasa P, Wongwiwat W, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol 2016; 17: 1102\u20138.","journal-title":"Nat Immunol"},{"key":"433_CR55","unstructured":"Halstead SB. Pathogenic exploitation of Fc activity. In: Ackerman M, ed. Antibody Fc linking adaptive and innate immunity. Cambridge, MA: Academic Press."},{"key":"433_CR56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fcimb.2018.00044","volume":"8","author":"MA Martin-Acebes","year":"2018","unstructured":"Martin-Acebes MA, Saiz JC, Jim\u00e9nez de Oya N. Antibody-dependent enhancement and Zika: real threat or phantom menace? Front Cell Infect Microbiol 2018; 8: 44.","journal-title":"Front Cell Infect Microbiol"},{"key":"433_CR57","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3389\/fimmu.2018.00597","volume":"9","author":"R Khandia","year":"2018","unstructured":"Khandia R, Munjal A, Dhama K, et al. Modulation of Dengue\/ Zika virus pathogenicity by antibody-dependent enhancement and strategies to protect against enhancement in Zika virus infection. Front Immunol 2018; 9: 597.","journal-title":"Front Immunol"},{"key":"433_CR58","volume-title":"WHO Director-General summarizes the outcome of the Emergency Committee regarding clusters of microcephaly and Guillain-Barr\u00e9 syndrome","author":"WHO.","year":"2016","unstructured":"WHO. WHO Director-General summarizes the outcome of the Emergency Committee regarding clusters of microcephaly and Guillain-Barr\u00e9 syndrome. http:\/\/www.who.int\/mediacentre\/news\/statements\/2016\/emergency-committee-zika-microcephaly\/en\/# (accessed February 1, 2016)."},{"key":"433_CR59","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/aji.12289","volume":"72","author":"K Racicot","year":"2014","unstructured":"Racicot K, Kwon JY, Aldo P, Silasi M, Mor G. Understanding the complexity of the immune system during pregnancy. Am J Reprod Immunol 2014; 72: 107\u201316.","journal-title":"Am J Reprod Immunol"},{"key":"433_CR60","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0140-6736(16)00320-2","volume":"387","author":"DL Heymann","year":"2016","unstructured":"Heymann DL, Hodgson A, Sall AA, et al. Zika virus and microcephaly: why is this situation a PHEIC? Lancet 2016; 387: 719\u201321.","journal-title":"Lancet"},{"key":"433_CR61","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S1473-3099(17)30727-2","volume":"18","author":"TVB de Ara\u00fajo","year":"2018","unstructured":"de Ara\u00fajo TVB, Ximenes RAA, Miranda-Filho DB, et al. Investigators from the Microcephaly Epidemic Research Group; Brazilian Ministry of Health; Pan American Health Organization; Instituto de Medicina Integral Professor Fernando Figueira; State Health Department of Pernambuco. Association between microcephaly, Zika virus infection and other risk factors in Brazil: final report of a case-control study. Lancet Infect Dis 2018; 18: 328\u201336.","journal-title":"Lancet Infect Dis"},{"key":"433_CR62","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/WNL.0b013e3181b783f7","volume":"73","author":"S Ashwal","year":"2009","unstructured":"Ashwal S, Michelson D, Plawner L, Dobyns WB, Quality Standards Subcommittee of the American Academy of Neurology, the Practice Committee of the Child Neurology Society. Practice parameter: evaluation of the child with microcephaly (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2009; 73: 887\u201397.","journal-title":"Neurology"},{"key":"433_CR63","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1473-3099(16)00095-5","volume":"16","author":"G Calvet","year":"2016","unstructured":"Calvet G, Aguiar RS, Melo ASO, et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 2016; 16: 653\u201360.","journal-title":"Lancet Infect Dis"},{"key":"433_CR64","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1523\/JNEUROSCI.3124-16.2017","volume":"37","author":"AN van den Pol","year":"2017","unstructured":"van den Pol AN, Mao G, Yang Y, Ornaghi S, Davis JN. Zika virus targeting in the developing brain. J Neurosci 2017; 37: 2161\u201375.","journal-title":"J Neurosci"},{"key":"433_CR65","doi-asserted-by":"publisher","first-page":"e0206093","DOI":"10.1371\/journal.pone.0206093","volume":"13","author":"F Diop","year":"2018","unstructured":"Diop F, Vial T, Ferraris P, et al. Zika virus infection modulates the metabolomic profile of microglial cells. PLoS One 2018; 13: e0206093.","journal-title":"PLoS One"},{"key":"433_CR66","doi-asserted-by":"publisher","first-page":"el70542","DOI":"10.1590\/0074-02760170542","volume":"113","author":"FG Naveca","year":"2018","unstructured":"Naveca FG, Pontes GS, Chang AY, et al. Analysis of the immunological biomarker profile during acute Zika virus infection reveals the overexpression of CXCL10, a chemokine linked to neuronal damage. Mem Inst Oswaldo Cruz 2018; 113: el70542.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"433_CR67","first-page":"21","volume":"3","author":"SS Foo","year":"2018","unstructured":"Foo SS, Chen W, Chan Y, et al. Biomarkers and immunoprofiles associated with fetal abnormalities of ZIKV-positive pregnancies. ICI Insight 2018; 3: 21.","journal-title":"ICI Insight"},{"key":"433_CR68","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri3070","volume":"11","author":"C Shi","year":"2011","unstructured":"Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011; 11: 762\u201374.","journal-title":"Nat Rev Immunol"},{"key":"433_CR69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/14728222.2017.1258402","volume":"21","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhang J, Luo P, Zhu J, Feng J, Zhang HL. Tumor necrosis factor-alpha in Guillain-Barr\u00e9 syndrome, friend or foe? Expert Opin Ther Targets 2017; 21: 103\u201312.","journal-title":"Expert Opin Ther Targets"},{"key":"433_CR70","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fimmu.2014.00298","volume":"5","author":"MM Faas","year":"2014","unstructured":"Faas MM, Spaans F, De Vos P. Monocytes and macrophages in pregnancy and pre-eclampsia. Front Immunol 2014; 5: 298.","journal-title":"Front Immunol"},{"key":"433_CR71","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1067\/mob.2001.117681","volume":"185","author":"MT Gervasi","year":"2001","unstructured":"Gervasi MT, Chaiworapongsa T, Naccasha N, et al. Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes. Am J Obstet Gynecol 2001; 185: 1124\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"433_CR72","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.placenta.2017.03.001","volume":"56","author":"MM Faas","year":"2017","unstructured":"Faas MM, de Vos P. Uterine NK cells and macrophages in pregnancy. Placenta 2017; 56: 44\u201352.","journal-title":"Placenta"},{"key":"433_CR73","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/intimm\/5.5.559","volume":"5","author":"S Saito","year":"1993","unstructured":"Saito S, Nishikawa K, Morii T, Enomoto M, Narita N, Motoyoshi K, Ichijo M. Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Int Immunol 1993; 5: 559\u201363.","journal-title":"Int Immunol"},{"key":"433_CR74","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/s41564-017-0016-3","volume":"2","author":"SS Foo","year":"2017","unstructured":"Foo SS, Chen W, Chan Y, et al. Asian Zika virus strains target CD14+ blood monocytes and induce M2-skewed immunosuppression during pregnancy. Nat Microbiol 2017; 2: 1558\u201370.","journal-title":"Nat Microbiol"},{"key":"433_CR75","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm1492","volume":"12","author":"DG Brooks","year":"2006","unstructured":"Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006; 12: 1301\u20139.","journal-title":"Nat Med"},{"key":"433_CR76","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.24839","volume":"81","author":"AM Ornelas","year":"2017","unstructured":"Ornelas AM, Pezzuto P, Silveira PP, et al. Immune activation in amniotic fluid from Zika virus-associated microcephaly. Ann Neurol 2017; 81: 152\u20136.","journal-title":"Ann Neurol"},{"key":"433_CR77","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doom PA. Guillain-Barr\u00e9 syndrome. Lancet 2016; 388: 717\u201327.","journal-title":"Lancet"},{"key":"433_CR78","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.medmal.2014.04.008","volume":"44","author":"S Ioos","year":"2014","unstructured":"Ioos S, Mallet HP, Leparc Goffart I, Gauthier V, Cardoso T, Herida M. Current Zika virus epidemiology and recent epidemics. Med Mal Infect 2014; 44: 302\u20137.","journal-title":"Med Mal Infect"},{"key":"433_CR79","volume-title":"WHO Emergencies preparedness, response. Guillain-Barr\u00e9 syndrome-Brazil.","author":"WHO.","year":"2016","unstructured":"WHO. WHO Emergencies preparedness, response. Guillain-Barr\u00e9 syndrome-Brazil. 2016. http:\/\/www.who.int\/csr\/don\/8-february-2016-gbs-brazil\/en\/ (accessed 19 February 2016)."},{"key":"433_CR80","doi-asserted-by":"publisher","first-page":"758639","DOI":"10.1155\/2014\/758639","volume":"2014","author":"KK Nyati","year":"2014","unstructured":"Nyati KK, Prasad KN. Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barr\u00e9 syndrome. Mediators Inflamm 2014; 2014: 758639.","journal-title":"Mediators Inflamm"},{"key":"433_CR81","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1038\/s41598-018-21025-5","volume":"8","author":"J Peng","year":"2018","unstructured":"Peng J, Zhang H, Liu P, et al. IL-23 and IL-27 levels in serum are associated with the process and the recovery of Guillain-Barr\u00e9 syndrome. Sci Rep 2018; 8: 2824.","journal-title":"Sci Rep"},{"key":"433_CR82","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/mus.23829","volume":"48","author":"S Chiang","year":"2013","unstructured":"Chiang S, Ubogu EE. The role of chemokines in Guillain-Barr\u00e9 syndrome. Muscle Nerve 2013; 48: 320\u201330.","journal-title":"Muscle Nerve"},{"key":"433_CR83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41541-018-0061-9","volume":"3","author":"ADT Barrett","year":"2018","unstructured":"Barrett ADT. Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation. NPJ Vaccines 2018; 3: 24.","journal-title":"NPJ Vaccines"},{"key":"433_CR84","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-med-040717-051127","volume":"70","author":"MS Diamond","year":"2019","unstructured":"Diamond MS, Ledgerwood JE, Pierson TC. Zika virus vaccine development: Progress in the face of new challenges. Annu Rev Med 2019; 70: 121\u201335.","journal-title":"Annu Rev Med"},{"key":"433_CR85","doi-asserted-by":"publisher","first-page":"el000369","DOI":"10.1371\/journal.ppat.1000369","volume":"5","author":"CQ Nie","year":"2009","unstructured":"Nie CQ, Bernard NJ, Norman MU, et al. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog 2009; 5: el000369.","journal-title":"PLoS Pathog"},{"key":"433_CR86","doi-asserted-by":"publisher","first-page":"e5263","DOI":"10.1371\/journal.pone.0005263","volume":"4","author":"O Grip","year":"2009","unstructured":"Grip O, Janciauskiene S. Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn\u2019s disease. PLoS One 2009; 4: e5263.","journal-title":"PLoS One"},{"key":"433_CR87","first-page":"121","volume":"22","author":"M Liu","year":"2011","unstructured":"Liu M, Guo S, Hibbert JM, et al. CXCLl0\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev 2011; 22: 121\u201330.","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["European Cytokine Network"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ecn.2019.0433.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ecn.2019.0433\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ecn.2019.0433.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ecn.2019.0433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:27:33Z","timestamp":1790674053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/ECN\/v30n3\/65388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1684\/ecn.2019.0433","relation":{},"ISSN":["1952-4005"],"issn-type":[{"value":"1952-4005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"6 Februar 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}